Company Filing History:
Years Active: 2018
Title: Efrain “Frank” Rodriguez: Innovator in Genomic Synthesis
Introduction
Efrain “Frank” Rodriguez is a notable inventor based in Bordentown, NJ (US). He has made significant contributions to the field of genomic synthesis, showcasing his expertise through innovative methods and technologies. His work is particularly focused on the synthesis of nucleic acids, which plays a crucial role in various scientific and medical applications.
Latest Patents
Frank Rodriguez holds a patent for "Genomic-scaled nucleic acid synthesis, and other combinatorial syntheses." This patent outlines a method of synthesis that includes several key steps. The process involves providing separate reaction sequences to TABs, utilizing reaction vessels designed for combinatorial building blocks, and operating TAB sorters equipped with advanced detection and sorting capabilities. The method is designed to efficiently conduct reactions and segregate TABs for further processing, ensuring high throughput and accuracy in genomic synthesis.
Career Highlights
Frank is currently employed at Pharmaseq, Inc., where he continues to develop and refine his innovative techniques. His work at Pharmaseq has positioned him as a leader in the field of genomic synthesis, contributing to advancements that have the potential to impact various areas of research and development.
Collaborations
Frank collaborates with talented professionals in his field, including Wlodek Mandecki and Ziye “Jay” Qian. These collaborations enhance the innovative environment at Pharmaseq, fostering the development of cutting-edge technologies in genomic synthesis.
Conclusion
Efrain “Frank” Rodriguez is a pioneering inventor whose work in genomic synthesis is paving the way for future advancements in biotechnology. His contributions, particularly through his patent, demonstrate his commitment to innovation and excellence in the field.